Lewy body pathology is associated with mitochondrial DNA damage in Parkinson's disease

Neurobiol Aging. 2013 Sep;34(9):2231-3. doi: 10.1016/j.neurobiolaging.2013.03.016. Epub 2013 Apr 6.

Abstract

Mitochondrial dysfunction has been strongly implicated in the pathogenesis of Parkinson's disease (PD) and Alzheimer's disease (AD), but its relation to protein aggregation is unclear. PD is characterized by synuclein aggregation (i.e., Lewy body [LB] formation). In AD, the abnormal accumulation of tau protein forms neurofibrillary tangles. In this study, we laser-dissected LB-positive and -negative neurons from the substantia nigra of postmortem PD brains, and tau-positive and -negative hippocampal neurons from AD brains. We quantified mitochondrial DNA deletions in relation to the cellular phenotype and in comparison with age-matched controls. Deletion levels were highest in LB-positive neurons of PD brains (40.5 ± 16.8%), followed by LB-negative neurons of PD cases (31.8 ± 14.4%) and control subjects (25.6 ± 17.5%; analysis of variance p < 0.005). In hippocampal neurons, deletion levels were 25%-30%, independent of disease status and neurofibrillary tangles. The presented findings imply increased mitochondrial DNA damage in LB-positive midbrain neurons, but do not support a direct causative link of respiratory chain dysfunction and protein aggregation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • DNA Damage*
  • DNA, Mitochondrial / genetics*
  • Female
  • Humans
  • Lewy Bodies / genetics*
  • Lewy Bodies / pathology*
  • Male
  • Mesencephalon / cytology
  • Neurons / cytology
  • Neurons / metabolism
  • Oxidative Stress / genetics
  • Oxidative Stress / physiology
  • Parkinson Disease / genetics*
  • Parkinson Disease / pathology*
  • Reactive Oxygen Species / metabolism
  • alpha-Synuclein / metabolism

Substances

  • DNA, Mitochondrial
  • Reactive Oxygen Species
  • SNCA protein, human
  • alpha-Synuclein